Aaron R. Hansen

Also affiliated with University of Toronto, Princess Alexandra Hospital, Princess Margaret Cancer Centre

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial”.

CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial

Investigational New Drugs(2024)10.1007/s10637-023-01410-2

N/A

1.3DataRank · unranked

67 citations

Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H. Miller, Aaron R. Hansen +12 more

Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development

Clinical and Translational Science(2022)10.1111/cts.13387

N/A

0.655DataRank · unranked

16 citations

Aaron R. Hansen, Glenn J. Hanna, Elena Garralda, Haeseong Park, James Strauss +11 more

Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab015

N/A

0DataRank · unranked

56 citations

Daniel Shepshelovich, Christina Gallagher, Lisa Wang, Albiruni R. Abdul Razak, Anna Spreafico +5 more

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102838

N/A

0DataRank · unranked

18 citations

Olalekan Lee Aiyegbusi, Emily Alger, Ethan Basch, Jill A. Bell, Vishal Bhatnagar +27 more

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable

UNC Libraries(2024)10.17615/ypmf-1g37

N/A

0DataRank · unranked

0 citations

Melanie Calvert, Steven Rizk, Philip Collis, Alastair Greystoke, Bellinda L. King‐Kallimanis +27 more

Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer(2023)10.1016/j.clgc.2023.02.010

N/A

0DataRank · unranked

58 citations

Michael T. Schweizer, Kim N., Rahul Aggarwal, Neeraj Agarwal, James L. Gulley +9 more

Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy

Nature Immunology(2022)10.1038/s41590-022-01262-7

N/A

0DataRank · unranked

52 citations

Ramy Gadalla, Heidi Elsaesser, Diala Abd-Rabbo, Rene Quevedo, S.Y. Cindy Yang +19 more